Management of Gallbladder Polyps

Size-Based Management Algorithm

• The American College of Radiology recommends gallbladder polyps be managed using a size-based and morphology-based risk stratification algorithm, with surgical consultation recommended for polyps ≥15 mm, individualized decision-making for polyps 10-14 mm, surveillance for polyps 6-9 mm with risk factors, and no follow-up for polyps <6 mm without concerning features 1, 2
• Polyps ≥15 mm have the highest malignancy risk, with size ≥15 mm being an independent risk factor for neoplastic lesions 1
• Neoplastic polyps average 18.1-18.5 mm compared to 7.5-12.6 mm for nonneoplastic polyps 1, 3

Morphology-Based Risk Stratification

• Pedunculated "ball-on-the-wall" polyps have a characteristic appearance with a thin stalk and are at minimal malignancy risk 4, 2, 5
• Sessile (broad-based) morphology is associated with higher malignancy risk compared to pedunculated polyps 6, 2
• Focal wall thickening ≥4 mm adjacent to the polyp is a concerning feature 2, 5

Growth Surveillance Criteria

• Growth of ≥4 mm within 12 months constitutes rapid growth and warrants surgical consultation 4, 6, 2, 5
• Most polyps remain stable over 3-10 years, but growth becomes more apparent with longer follow-up 1, 3

Special Population: Primary Sclerosing Cholangitis

• Patients with PSC have dramatically elevated malignancy risk (18-50%) and require a lower threshold for intervention 2, 5
• Consider cholecystectomy for polyps ≥8 mm in PSC patients 2, 5

Diagnostic Optimization

• Transabdominal ultrasound with proper fasting preparation is the primary diagnostic modality 2, 5
• Contrast-enhanced ultrasound (CEUS) is preferred for polyps ≥10 mm when differentiation from tumefactive sludge or adenomyomatosis is challenging 2, 5

Critical Pitfalls to Avoid

• Tumefactive sludge is mobile and layering, while true polyps are fixed, non-mobile, and non-shadowing 5
• 60% of gallbladder polyps are benign cholesterol polyps with negligible malignancy risk 5

Gallbladder Polyp Surveillance Guidelines

Introduction to Surveillance

• The American College of Radiology recommends that gallbladder polyps do not universally require yearly monitoring, with surveillance intervals depending on polyp size, morphology, and risk stratification, and most small polyps requiring no follow-up at all, with surveillance limited to a maximum of 2-3 years when indicated 7, 8

Size-Based Surveillance Algorithm

• Polyps ≤5-6 mm without risk factors require no surveillance whatsoever, as the malignancy risk is virtually zero, with no documented cases of malignancy in polyps <10 mm at initial detection in large series involving approximately 3 million gallbladder ultrasounds 9
• Pedunculated "ball-on-the-wall" polyps ≤9 mm require no follow-up, as they have an extremely low risk configuration with a thin stalk attachment 8, 9

Maximum Surveillance Duration

• Extended surveillance beyond 3-4 years is not productive and should be discontinued, as 68% of gallbladder cancers associated with polyps are detected within the first year after initial detection, and after 4 years of follow-up, only one cancer was found in 137,633 person-years of surveillance 7

Growth Triggers for Surgical Consultation

• Growth of ≥4 mm within any 12-month period constitutes rapid growth and warrants immediate surgical consultation, regardless of absolute polyp size, as rapid sustained growth (≥4 mm/year) is concerning, with anecdotal reports of polyps growing from 7 to 16 mm over 6 months developing into malignancy 7, 9

Risk Factors That Modify Surveillance Strategy

• Sessile morphology (broad-based attachment) is a risk factor that lowers the threshold for surveillance in smaller polyps (6-9 mm) 8

Natural History of Polyps

• Natural polyp fluctuation of 2-3 mm is expected, and almost half of polyps increase or decrease in size as part of their natural history, which should not trigger unnecessary intervention 7, 9

Management of Small Nonmobile Gallbladder Polyps

Risk Stratification

• The American College of Radiology recommends that a 7 mm nonmobile gallbladder polyp with internal vascularity is considered intermediate-risk, with a malignancy rate of 8.7 per 100,000 patients, significantly higher than polyps <6 mm but lower than polyps ≥10 mm 10
• Sessile polyps, like the one described, have consistently higher rates of malignancy compared to pedunculated polyps across multiple studies, according to the Radiological Society of North America 11, 12
• The presence of internal vascularity on Doppler imaging confirms that this is a true polyp rather than tumefactive sludge, which would be avascular, as stated by the American Institute of Ultrasound in Medicine 12

Surveillance Protocol

• The American College of Radiology recommends follow-up ultrasound at 6 months, 1 year, and 2 years for a 7 mm nonmobile gallbladder polyp with internal vascularity, based on evidence showing that 68% of gallbladder cancers associated with polyps are detected within the first year 11
• Surveillance should be discontinued after 2 years if the polyp remains stable in size, with no growth of ≥2 mm, or if the polyp disappears, which occurs in up to 34% of cases, according to the Society of Radiologists in Ultrasound 10

Triggers for Surgical Consultation

• Immediate surgical referral is warranted if the polyp grows to ≥10 mm, which represents the established threshold for cholecystectomy regardless of other features, as recommended by the Society of Surgical Oncology 12
• Rapid growth of ≥4 mm within 12 months constitutes concerning rapid growth, even if the absolute size remains <10 mm, and requires immediate surgical referral, according to the American College of Surgeons 11

Management of Small Asymptomatic Gallbladder Polyps

Risk Assessment

• Polyps ≤ 6 mm have virtually zero malignancy risk; in a pooled analysis of ≈ 3 million gallbladder ultrasounds, the malignancy rate was 0 % for polyps < 5 mm and no cancers were identified in polyps < 10 mm at initial detection. Radiology (2022) 13 – High‑quality large observational data.

Guideline Recommendations

• The 2022 Society of Radiologists in Ultrasound consensus states that low‑risk patients with gallbladder polyps ≤ 6 mm require no follow‑up imaging. Radiology (2022) 13 – Consensus guideline.
• Cholecystectomy is recommended only for polyps ≥ 10 mm; operating on a 6‑mm polyp would expose patients to unnecessary operative morbidity (2–8 %) and mortality (0.2–0.7 %). Radiology (2022) 13 – Guideline‑based recommendation with reported complication rates.
• Liver function tests are not indicated for incidental, asymptomatic gallbladder polyps and are not included in any guideline‑recommended evaluation pathway. Radiology (2022) 13 – Guideline recommendation.

Diagnostic Clarification

• If ultrasound cannot definitively differentiate a true polyp from tumefactive sludge, a repeat scan after fasting or a contrast‑enhanced ultrasound should be performed to clarify the finding. Radiology (2022) 14 – Expert recommendation.

Management of Small Asymptomatic Gallbladder Polyps

Guideline Recommendations (Society of Radiologists in Ultrasound)

• The SRU 2022 consensus guideline strongly recommends that gallbladder polyps ≤6 mm in patients without malignancy risk factors require no follow‑up imaging. 15
• According to the SRU 2022 guideline, cholecystectomy is indicated only for polyps ≥10 mm or for polyps with concerning features; therefore surgical consultation is unnecessary for a 6 mm polyp. 15

Morphology‑Based Size Thresholds

• The SRU 2022 guideline states that pedunculated (ball‑on‑the‑wall) polyps ≤9 mm and sessile polyps ≤6 mm do not require follow‑up, regardless of shape. A 6 mm polyp meets both criteria. 15

Surveillance Imaging Schedule

• The SRU 2022 guideline specifies that polyps 7–9 mm with low‑risk morphology should have an initial ultrasound at 12 months, and polyps 10–14 mm should be imaged at 6 months; thus a 6 mm polyp does not merit a 6‑month follow‑up ultrasound. 15

Natural History of Small Polyps

• Radiology 2022 data indicate that approximately 50 % of gallbladder polyps demonstrate size fluctuations of 2–3 mm over time without clinical significance, so minor changes should not trigger intervention. 16